MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Suggested protocol for electroconvulsive therapy for depression in a Parkinson’s disease patient with a deep brain stimulator: A case report

K. Dashtipour, M. Pereau, D. Trenkle, C. Osorio, K. Stoletniy (Loma Linda, CA, USA)

Meeting: 2016 International Congress

Abstract Number: 114

Keywords: Anxiety, Parkinsonism, Subthalamic nucleus(SIN)

Session Information

Date: Monday, June 20, 2016

Session Title: Surgical therapy: Parkinson's disease

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To report an evidence for safety of ECT in patients with DBS in place.

Background: We report a case of bilateral electroconvulsive therapy (ECT) conjointly done in a patient with a deep brain stimulator (DBS) in place for Parkinson’s disease (PD), to show that it can be accomplished safely and effectively. There is currently limited data available on the use of ECT in the presence of the DBS.

Methods: We report the successful treatment of an episode of major depression with psychotic features and severe suicidality with electroconvulsive therapy (ECT) in a 48-year-old male with Parkinson’s disease who had a bilateral subthalamic nucleus deep-brain stimulator (DBS) in place five years prior to presentation at our hospital. We used the Thymatron IV System, and a stimulus of 15% of maximum charge and 0.5 PW was utilized based on evidence published in Clinical Manual of Electroconvulsive Therapy by Mehul Mankad, M.D, et. al. related to known seizure thresholds and to ensure adequate dosing in a male BL patient. His last treatment was at a stimulus of 100% maximum charge and lasted 51 seconds on EEG with a 42 second motor seizure. This was the patient’s 13th treatment and only 11th seizure.

Results: ECT was effectively and safely utilized to treat the patient’s depression as well as psychosis without harming the patient or damaging the DBS hardware. A Montgomery Asberg Depression Rating Scale (MADRS), Spanish version, was done on a weekly basis to assess improvements on mood. The first MADRS performed on 5/22/15 was 47. By treatment #11 and seizure # 9 the MADRS score had decreased to 8. The patient received a total of 13 treatments. The patient’s Parkinson’s symptoms also decreased and he required less medication upon discharge from the hospital.

Conclusions: As DBS and ECT are becoming more commonplace as a therapeutic treatment for patient’s with PD it is our goal is to add to the growing body of evidence about the safety and efficacy of ECT in patients with DBS as well as provide a suggested protocol for treatments. The technique herein described may be applicable to other patients who have co morbid PD with DBS who need ECT.

To cite this abstract in AMA style:

K. Dashtipour, M. Pereau, D. Trenkle, C. Osorio, K. Stoletniy. Suggested protocol for electroconvulsive therapy for depression in a Parkinson’s disease patient with a deep brain stimulator: A case report [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/suggested-protocol-for-electroconvulsive-therapy-for-depression-in-a-parkinsons-disease-patient-with-a-deep-brain-stimulator-a-case-report/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/suggested-protocol-for-electroconvulsive-therapy-for-depression-in-a-parkinsons-disease-patient-with-a-deep-brain-stimulator-a-case-report/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley